Advancements in myelofibrosis management: a comprehensive analysis of Ojjaara (Momelotinib) therapy and clinical perspectives
Areeba Aamir Ali Basaria(Dow University of Health Sciences), Aymar Akilimali(Roslin Institute), Areeba Ahsan(Foundation University Medical College), Rabeea Tariq(Dow University of Health Sciences), Jospin Bisimwa(Université Evangélique en Afrique), Rodrigue Fikiri Bavurhe(Université Officielle de Bukavu), John-Peter Mulindwa Murhula(Université Evangélique en Afrique), Calvin R. Wei(Unknown)
Cited by 0
Related Papers
Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease
|Annals of Medicine and Surgery|2024|87
Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa
|Annals of Medicine and Surgery|2023|30
Self-medication and Anti-malarial Drug Resistance in the Democratic Republic of the Congo (DRC): A silent threat
|Tropical Medicine and Health|2022|29
Barriers Encountered Toward Pursuing a Neurosurgical Career: A Cross-Sectional Study Among Medical Students, Interns, and Junior Doctors in Africa
|World Neurosurgery|2022|26
The unmet need of organ transplantation in Africa
|International Journal of Surgery|2023|21